Trials / Completed
CompletedNCT01554917
A Study of Iguratimod in Patients With Active Rheumatoid Arthritis
A Phase IV Study of Iguratimod in Patients With Active Rheumatoid Arthritis (RA)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,759 (actual)
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to evaluate the safety and efficacy of Iguratimod in patients with active Rheumatoid Arthritis.
Detailed description
This is a multi-center, open, single arm study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iguratimod | taken orally, 2 tablets/day (bid) |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2012-03-15
- Last updated
- 2020-10-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01554917. Inclusion in this directory is not an endorsement.